3Savino Bruno,John M. Vierling,Rafael Esteban,Lisa M. Nyberg,Hugo Tanno,Zachary Goodman,Fred Poordad,Bruce Bacon,Keith Gottesdiener,Lisa D. Pedicone,Janice K. Albrecht,Clifford A. Brass,Seth Thompson,Margaret H. Burroughs.Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis[J]. Journal of Hepatology . 2012
4Bacon Bruce R,Gordon Stuart C,Lawitz Eric,Marcellin Patrick,Vierling John M,Zeuzem Stefan,Poordad Fred,Goodman Zachary D,Sings Heather L,Boparai Navdeep,Burroughs Margaret,Brass Clifford A,Albrecht Janice K,Esteban Rafael.Boceprevir for previously treated chronic HCV genotype 1 infection. The New England Quarterly . 2011
5Ziol M,Handra-Luca A,Kettaneh A,Christidis C,Mal F,Kazemi F,de Lédinghen V,Marcellin P,Dhumeaux D,Trinchet JC,Beaugrand M.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology . 2005
6Poordad Fred,McCone Jonathan,Bacon Bruce R,Bruno Savino,Manns Michael P,Sulkowski Mark S,Jacobson Ira M,Reddy K Rajender,Goodman Zachary D,Boparai Navdeep,DiNubile Mark J,Sniukiene Vilma,Brass Clifford A,Albrecht Janice K,Bronowicki Jean-Pie.Boceprevir for untreated chronic HCV genotype 1 infection. The New England Quarterly . 2011
7Massimo Colombo,Simone Strasser,Christophe Moreno,Paulo Abrao Ferreira,Petr Urbanek,Inmaculada Fernández,Djamal Abdurakmonov,Adrian Streinu-Cercel,Anke Verheyen,Wafae Iraqi,Ralph DeMasi,Andrew Hill,Isabelle Lonjon-Domanec,Heiner Wedemeyer.??Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program(J)Journal of Hepatology . 2014 (5)
8Stuart C. Gordon,Andrew J. Muir,Joseph K. Lim,Brian Pearlman,Curtis K. Argo,Ananthakrishnan Ramani,Benedict Maliakkal,Imtiaz Alam,Thomas G. Stewart,Monika Vainorius,Joy Peter,David R. Nelson,Michael W. Fried,K. Rajender Reddy.??Safety Profile of Boceprevir and Telaprevir in Chronic Hepatitis C: Real-World Experience From HCV-TARGET(J)Journal of Hepatology . 2014
9Ferenci P,Caruntu FA,Lengyel G,Messinger D,Bakalos G,Flisiak R.Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Na?ve Hepatitis C Virus Genotype 1 Patients:International Phase IIIb/IV Tri Co Trial. Infect Dis Ther . 2016
10Hézode C,Fontaine H,Dorival C,Zoulim F,Larrey D,Canva V,De Ledinghen V,Poynard T,Samuel D,Bourliere M,Alric L,Raabe JJ,Zarski JP,Marcellin P,Riachi G,Bernard PH,Loustaud-Ratti V,Chazouilleres O,Abergel A,Guyader D,Metivier S,Tran A,Di Martino V,Causse X.Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology . 2014
